Seres Therapeutics, Inc. (MCRB) has a market capitalization of $82.54M and trades at $8.61. The 52-week range is 6.53-29.98.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 13.5, Earnings Per Share (EPS) of $0.64, annual revenue of $789K.
The stock has a beta of 0.26, operates in the Healthcare sector.
